Tepezza is a medicine used to treat adults with moderate to severe thyroid eye disease (TED, also known as Graves’ eye disease), an autoimmune disease that triggers inflammation of muscles, fat, and other tissues around and behind the eyes. This can push the eyes forward causing them to bulge. An autoimmune disease is caused by the body’s own defence system attacking normal tissue. Tepezza contains the active substance teprotumumab.
Therapeutic Indication
### Therapeutic indication Treatment of moderate to severe thyroid eye disease (TED).
Therapeutic Area (MeSH)
ATC Code
L04AG13
ATC Item
teprotumumab
Pharmacotherapeutic Group
N/A
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| teprotumumab | N/A | Teprotumumab |
EMA Name
Tepezza
Medicine Name
Tepezza
Aliases
N/ANo risk management plan link.
